%PDF-1.4
%
54 0 obj
<>
endobj
51 0 obj
<>
endobj
108 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2005-07-05T17:07:45Z
2024-03-28T15:17:27-07:00
QuarkXPressª: AdobePS 8.8.0 (301)
2024-03-28T15:17:27-07:00
application/pdf
Heather
2004-531.aug
uuid:dd72d534-1dd1-11b2-0a00-ea0927fd5800
uuid:dd72d537-1dd1-11b2-0a00-6a0000000000
endstream
endobj
40 0 obj
<>
endobj
41 0 obj
<>
endobj
55 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 22 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 24 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 26 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 28 0 R/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 30 0 R/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 32 0 R/Type/Page>>
endobj
16 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 34 0 R/Type/Page>>
endobj
134 0 obj
[138 0 R]
endobj
135 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
13.5 787.5 585 -783 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 56.468 737.0293 Tm
[(18.)-875.1 (Rejeski )17.7 (WJ, Mihalko SL. Physical activity and quality of life in)]TJ
2.175 -1.25 Td
[(older adults. J Gerontol )54.8 (A)-220.1 (Biol Sci Med Sci 2001;56 Spec No )]TJ
0 Tw 0 -1.25 TD
(2:23-35.)Tj
0.02499 Tw -2.175 -1.25 Td
[(19.)-875.1 (Slemenda C, Heilman DK, Brandt KD, et al. Reduced quadriceps)]TJ
2.175 -1.25 Td
(strength relative to body weight: a risk factor for knee osteoarthritis)Tj
T*
[(in women? )54.8 (Arthritis Rheum 1998;41:1951-9.)]TJ
-2.175 -1.25 Td
[(20.)-875.1 (Brandt KD, Heilman DK, Slemenda C, et al. Quadriceps strength in)]TJ
2.175 -1.25 Td
(women with radiographically progressive osteoarthritis of the knee)Tj
T*
(and those with stable radiographic changes. J Rheumatol)Tj
0 Tc 0 Tw T*
(1999;26:2431-7.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(21.)-875.1 (McAlindon )17.7 (TE, Cooper C, Kirwan JR, Dieppe P)91.7 (A. Determinants of)]TJ
2.175 -1.25 Td
[(disability in osteoarthritis of the knee. )54.8 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(1993;52:258-62.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(22.)-875.1 (Stevens JE, Mizner RL, Snyder)19.7 (-Mackler L. Quadriceps strength)]TJ
2.175 -1.25 Td
(and volitional activation before and after total knee arthroplasty for)Tj
T*
(osteoarthritis. J Orthop Res 2003;21:775-9.)Tj
-2.175 -1.25 Td
[(23.)-875.1 (Huang CH, Cheng CK, Lee )36.8 (YT)73.9 (, Lee KS. Muscle strength after )]TJ
2.175 -1.25 Td
(successful total knee replacement: a 6- to 13-year followup. Clin)Tj
T*
(Orthop Relat Res 1996;328:147-54.)Tj
-2.175 -1.25 Td
[(24.)-875.1 (Silva M, Shepherd EF)79.7 (, Jackson )17.7 (WO, Pratt JA, McClung CD,)]TJ
2.175 -1.25 Td
[(Schmalzried )17.7 (TP)110.7 (. Knee strength after total knee arthroplasty)64.8 (. )]TJ
-0.0298 Tw T*
[(J Arthroplasty )-54.8 (2003;18:605-1)36.8 (1.)]TJ
0.02499 Tw -2.175 -1.25 Td
[(25.)-875.1 (Lorentzen JS, Petersen MM, Brot C, Madsen OR. Early changes in)]TJ
2.175 -1.25 Td
[(muscle strength after total knee arthroplasty)64.8 (. )54.8 (A)-220.1 (6-month follow-up)]TJ
T*
[(of 30 knees. )54.8 (Acta Orthop Scand 1999;70:176-9.)]TJ
-2.175 -1.25 Td
[(26.)-875.1 (Stevens JE, Mizner RL, Snyder)19.7 (-Mackler L. Neuromuscular )]TJ
2.175 -1.25 Td
(electrical stimulation for quadriceps muscle strengthening after)Tj
T*
(bilateral total knee arthroplasty: a case series. J Orthop Sports Phys)Tj
T*
(Ther 2004;34:21-9.)Tj
-2.175 -1.25 Td
[(27.)-875.1 (Mizner RL, Stevens JE, Snyder)19.7 (-Mackler L. )17.7 (V)128.9 (oluntary activation)]TJ
2.175 -1.25 Td
(and decreased force production of the quadriceps femoris muscle)Tj
T*
[(after total knee arthroplasty)64.8 (. Phys )17.7 (Ther 2003;83:359-65.)]TJ
-2.175 -1.25 Td
[(28.)-875.1 (Snyder)19.7 (-Mackler L, De Luca PF)79.7 (, )17.7 (W)39.9 (illiams PR, Eastlack ME,)]TJ
2.175 -1.25 Td
[(Bartolozzi )54.8 (AR 3rd. Reflex inhibition of the quadriceps femoris)]TJ
T*
(muscle after injury or reconstruction of the anterior cruciate )Tj
T*
[(ligament. J Bone Joint Sur)17.7 (g )54.8 (Am 1994;76:555-60.)]TJ
-2.175 -1.25 Td
[(29.)-875.1 (Cibere J, Bellamy N, )17.7 (Thorne )54.8 (A, et al. Reliability of the knee )]TJ
2.175 -1.25 Td
[(examination in osteoarthritis: ef)17.7 (fect of standardization. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 2004;50:458-68.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(30.)-875.1 (Podsiadlo D, Richardson S. )17.7 (The timed \322Up & Go\323: a test of basic)]TJ
2.175 -1.25 Td
[(functional mobility for frail elderly persons. J )54.8 (Am Geriatr Soc)]TJ
0 Tc 0 Tw T*
(1991;39:142-8.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(31.)-875.1 (Rejeski )17.7 (WJ, Ettinger )17.7 (WH Jr)39.7 (, Schumaker S, James P)110.7 (, Burns R, Elam)]TJ
2.175 -1.25 Td
[(JT)73.9 (. )54.8 (Assessing performance-related disability in patients with knee)]TJ
T*
(osteoarthritis. Osteoarthritis Cartilage 1995;3:157-67.)Tj
-2.175 -1.25 Td
[(32.)-875.1 (Ettinger )17.7 (WH Jr)39.7 (, Burns R, Messier SP)110.7 (, et al. )54.8 (A)-220.1 (randomized trial )]TJ
2.175 -1.25 Td
(comparing aerobic exercise and resistance exercise with a health)Tj
T*
[(education program in older adults with knee osteoarthritis. )17.7 (The)]TJ
T*
[(Fitness )54.7 (Arthritis and Seniors )17.6 (T)35 (rial \(F)73.9 (AST\). JAMA)-220.2 (1997;277:25-31.)]TJ
-2.175 -1.25 Td
[(33.)-875.1 (W)79.9 (are JE Jr)39.7 (, Kosinski M, Bayliss MS, McHorney CA, Rogers )17.7 (WH,)]TJ
2.175 -1.25 Td
[(Raczek )54.8 (A. Comparison of methods for the scoring and statistical)]TJ
T*
(analysis of SF-36 health profile and summary measures: summary)Tj
T*
[(of results from the Medical Outcomes Study)64.8 (. Med Care 1995;33)]TJ
T*
(Suppl 4:AS264-79.)Tj
30.825 66.25 Td
[(34.)-875.1 (Brazier JE, Harper R, Munro J, )17.7 (W)79.9 (alters SJ, Snaith ML. Generic and)]TJ
2.175 -1.25 Td
(condition-specific outcome measures for people with osteoarthritis)Tj
T*
(of the knee. Rheumatology Oxford 1999;38:870-7.)Tj
-2.175 -1.25 Td
[(35.)-875.1 (Irr)17.7 (gang JJ, Snyder)19.7 (-Mackler L, )17.7 (W)79.9 (ainner RS, Fu FH, Harner CD.)]TJ
2.175 -1.25 Td
(Development of a patient-reported measure of function of the knee.)Tj
T*
[(J Bone Joint Sur)17.7 (g )54.8 (Am 1998;80:1)36.8 (132-45.)]TJ
-2.175 -1.25 Td
[(36.)-875.1 (Marx RG, Jones EC, )54.8 (Allen )54.8 (AA, et al. Reliability)64.8 (, validity)64.9 (, and)]TJ
2.175 -1.25 Td
(responsiveness of four knee outcome scales for athletic patients.)Tj
0 Tc T*
[(J Bone Joint Sur)17.8 (g )54.8 (Am 2001;83:1459-69.)]TJ
-0.00011 Tc -2.175 -1.25 Td
[(37.)-875.1 (W)79.9 (are J, Kosinski M, Gandek B. SF-36 Health Survey: manual and)]TJ
2.175 -1.25 Td
(interpretation guide. Lincoln, RI: QualityMetric Inc.; 1993, 2002.)Tj
-2.175 -1.25 Td
[(38.)-875.1 (Anouchi )36.8 (YS, McShane M, Kelly F Jr)39.7 (, Elting J, Stiehl J. Range of)]TJ
2.175 -1.25 Td
(motion in total knee replacement. Clin Orthop 1996;331:87-92.)Tj
-2.175 -1.25 Td
[(39.)-875.1 (Ethgen O, Bruyere O, Richy F)79.7 (, Dardennes C, Reginster JY)128.8 (. )]TJ
2.175 -1.25 Td
[(Health-related quality of life in total hip and total knee arthroplasty)64.8 (.)]TJ
T*
[(A)-220.1 (qualitative and systematic review of the literature. J Bone Joint)]TJ
0 Tc -0.02991 Tw T*
[(Sur)17.8 (g Am )-54.9 (2004;86:963-74.)]TJ
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(40.)-875.1 (Mancuso CA, Ranawat CS, Esdaile JM, Johanson NA, Charlson)]TJ
2.175 -1.25 Td
(ME. Indications for total hip and total knee arthroplasties. Results)Tj
T*
[(of orthopaedic surveys. J )54.8 (Arthroplasty 1996;1)36.8 (1:34-46.)]TJ
-2.175 -1.25 Td
[(41.)-875.1 (Slemenda C, Brandt KD, Heilman DK, et al. Quadriceps weakness)]TJ
2.175 -1.25 Td
[(and osteoarthritis of the knee. )54.8 (Ann Intern Med 1997;127:97-104.)]TJ
-2.175 -1.25 Td
[(42.)-875.1 (Fitzgerald JD, Orav EJ, Lee )17.7 (TH, et al. Patient quality of life during)]TJ
2.175 -1.25 Td
[(the 12 months following joint replacement sur)17.7 (gery)64.8 (. )54.8 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(2004;51:100-9.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(43.)-875.1 (van Baar ME, )54.8 (Assendelft )17.7 (WJ, Dekker J, Oostendorp RA, Bijlsma)]TJ
2.175 -1.25 Td
[(JW)91.7 (. Ef)17.7 (fectiveness of exercise therapy in patients with osteoarthritis)]TJ
T*
(of the hip or knee: a systematic review of randomized clinical )Tj
T*
[(trials. )54.8 (Arthritis Rheum 1999;42:1361-9.)]TJ
-2.175 -1.25 Td
[(44.)-875.1 (Fisher NM, Pender)17.7 (gast DR, Gresham GE, Calkins E. Muscle )]TJ
2.175 -1.25 Td
[(rehabilitation: its ef)17.7 (fect on muscular and functional performance of)]TJ
T*
[(patients with knee osteoarthritis. )54.8 (Arch Phys Med Rehabil)]TJ
0 Tc 0 Tw T*
(1991;72:367-74.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(45.)-875.1 (Baker K, McAlindon )17.7 (T)74 (. Exercise for knee osteoarthritis. Curr Opin)]TJ
2.175 -1.25 Td
(Rheumatol 2000;12:456-63.)Tj
-2.175 -1.25 Td
[(46.)-875.1 (T)69.9 (opp R, )17.7 (W)79.9 (oolley S, Hornyak J 3rd, Khuder S, Kahaleh B. )17.7 (The)]TJ
2.175 -1.25 Td
[(ef)17.7 (fect of dynamic versus isometric resistance training on pain and)]TJ
T*
[(functioning among adults with osteoarthritis of the knee. )54.8 (Arch Phys)]TJ
T*
[(Med Rehabil 2002;83:1)36.8 (187-95.)]TJ
-2.175 -1.25 Td
[(47.)-875.1 (Fransen M, Crosbie J, Edmonds J. Physical therapy is ef)17.7 (fective for)]TJ
2.175 -1.25 Td
(patients with osteoarthritis of the knee: a randomized controlled)Tj
T*
(clinical trial. J Rheumatol 2001;28:156-64.)Tj
-2.175 -1.25 Td
[(48.)-875.1 (Rogind H, Bibow-Nielsen B, Jensen B, Moller HC, Frimodt-Moller)]TJ
2.175 -1.25 Td
[(H, Bliddal H. )17.7 (The ef)17.7 (fects of a physical training program on patients)]TJ
T*
[(with osteoarthritis of the knees. )54.8 (Arch Phys Med Rehabil)]TJ
0 Tc 0 Tw T*
(1998;79:1421-7.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(49.)-875.1 (Rodgers JA, Garvin KL, )17.7 (W)79.9 (alker CW)91.7 (, Morford D, Urban J, Bedard)]TJ
2.175 -1.25 Td
[(J. Preoperative physical therapy in primary total knee arthroplasty)64.8 (.)]TJ
-0.0298 Tw T*
[(J Arthroplasty )-54.8 (1998;13:414-21.)]TJ
0.02499 Tw -2.175 -1.25 Td
[(50.)-875.1 (Beaupre LA, Lier D, Davies DM, Johnston DB. )17.7 (The ef)17.7 (fect of a )]TJ
2.175 -1.25 Td
(preoperative exercise and education program on functional )Tj
T*
[(recovery)64.9 (, health related quality of life, and health service utilization)]TJ
T*
[(following primary total knee arthroplasty)64.8 (. J Rheumatol)]TJ
0 Tc 0 Tw T*
[(2004;31:1)36.9 (166-73.)]TJ
ET
0 0 0 1 K
53.468 76.5 m
558.468 76.5 l
S
0 0 0 0 k
494.29 69.365 64.178 -15.665 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
8 0 0 8 541.468 56.4344 Tm
(1539)Tj
ET
0 0 0 0 k
53.532 70.51 247 -16.506 re
f*
BT
0 0 0 1 k
/T1_1 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.532 56.7384 Tm
[(Mizner)110.7 (, et al: Pr)36.8 (eoperative str)36.8 (ength pr)36.8 (edicts function after TKA)]TJ
ET
0 0 0 0 k
/GS0 gs
103.631 82.583 407.5 -10.833 re
f*
0.5 w
/GS1 gs
103.631 82.583 407.5 -10.833 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_2 8 Tf
108.828 74 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2005. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
34 0 obj
<>stream
8;Z\6>>bPh#itt$j>rTlkm+OgFuMI2=Gt0S$/s9R6S]b\7hu]oO($qlF8U\2n0d1`
0B\9]\3u^gaR1uN(A>\qQ-'T?Fg[89lsR#V[U-^nN%.rZn9TWl/=I@)r'9*XiqjVe
(^!qu$F!_g=OJ'f*3`Ma=g:Jk?;'0m9`B?mjHC*6L9`l,_Z4bJ4ieAN(3gonp0^F5
XBZd6nh>C_>Zj;j?!$fBX'#JVe>(.B,hZr0Ug-S.;&>je["'-O+*%WST;#OJ8M7@I
0^&N>LP4H,^q=H9SXQ&*08lS^>ogn1'5gsg7]\,*EQ"Q\_Hn[j[VF=rKQj[<*f3AR*4@k%3o0L)e/
OJ:gKoE_sYr>d1dqh!^l3KGZTc:JI:GS3`%f7]nU6D(E^(n2(^B$'Hp_P'@01!qk4
]_6*`eb@_MOA?ijr5>2i."/QB9[_<3gq].9$t65XRr:+L/LI2F<.6ep$f!:$)IDiY
RJ2d[j?JHf-'GH%'5\,+(!O>T`.mY`VH.ipR/XO47mbT=8Lg%&;[$&'@Jj>X4gD\@
OhH(62H89V-(4QNPLh#qTg#8U`l(6n[e:PKQngn0f?fBT#$oXBa#@aFG)H\K-
D?Fe`H;sWR[k6q_%Ja##[L=-DM'Dg#piV1rH7;0BCk]O1YWt!$m^!Ue;JO(_*-U(K
RoL#+Ma?e>1(3A6D@U7#-o-OX#'/.W==6*'!ZcB?!*0'L6oUPtVS:j,.:(6J[bP@r
L>X*dd77/3^:LP`O;^WXI]5rAn1J=O5]M
Ch6rU!%99#L]~>
endstream
endobj
38 0 obj
[/Indexed/DeviceRGB 255 37 0 R]
endobj
37 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
69 0 obj
<>
endobj
57 0 obj
<>
endobj
93 0 obj
<>
endobj
113 0 obj
<>
endobj
58 0 obj
<>
endobj
84 0 obj
<>stream
HtTyPWfpi[( (q]DEA9fAp2H2K
, .@*k-c\CyT6&ln^~YZ0sZ!/PuJ!Y>_+Dϴ1lLZZ~=gؿ
߬`СmraNooK54@l27?ʃ]s.yg}7Tqɪ=!1JjtdUB=^KNE̩K)U J]65iZ緞S&F/8ԫJZ[H"Ya",{"\UV(H,Eb\̈XbQj1)^&leNp#FKvKڥ
i<+\=6mNٺV~?#rsFvn_9:=f2|q
*6:
:9ttuv]A+.Eb͇q27:\
)XxC\ bsߎ(xaLo.:xNFJZ0ݬkh=QS.LuXn2uk/!+Xtu8Iֶ}k̆mK&nQ12٩ͩ2!j
уik7{dDv5
WhT#(`ip҂?X1(F"98DA:6zK\(!:_yDɄ_)Q11:@3
iM8h bR"csm$SBNj0o%0@b^,xL& BOᝠAhDs9/Um"[{]rtMUkEs._,:S_`/*e3?xkp?{-&ļ;ԁ
BqsWm!"佝1NCqkEC,Ax:\pYAc?|
[9RW|uP֣@"ĆbK3pO Fr/vp`"棴}Y_0[:sR%|~*|N(nקKy3R(~ˉh$`$OPMah ]tC0D(sP")!E=)9fvh1dZlj -ofj
}ymF(FK_x|+_3i^zlTQo'G\5Β} kyI}07}.4.>gsI+rr,X.P[Gu{nՄ&1&ZV%]RxI>ɞt
nSiwd=ɐ퀧MLvxW0W$fE3myEL/A,%Ɵѳ1\b.)^
^p;nx_2EQHVuNP\c'FF՞
luUlm?U{~nF+ֲK|8ZiA>) !Ph8h H\G;py'LY@~H"h,Hz(O y |$
.g
:Bj ?#1
(<?DSž+Vfɾ
}擪
L?X,CV Tɀɔ+TSxQBtJ|'3h*sF|'h&{f?tWmT>3KjEmgp6=!5դjFQ *"eV>ݝeOV]\ECP+6ǚZ=wq8=G~=y}?{ѶQ7u1
%!ȳ|JTRx
7qe3qX]7PwU84ҋDfV!3j.InwKUygf
N_q7dZU%jQ:bPEf=zy-%#"BfE߇y!BcIڄǓ~Յ
ăf^ZK^/B8lD&Gj'!rh,>Gr.{i\`sy&b
ynpQ4
sUĢ{P@ft¯:]iP_"4L*CZ?jbDYoŐXSZ횦Iu{96A!